{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Kristina Bennet Emdal"}, {"accession": "MS:1000589", "name": "contact email", "value": "kbemdal@mit.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Massachusetts Institute of Technology"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Forest White"}, {"accession": "MS:1000589", "name": "contact email", "value": "fwhite@mit.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Massachusetts Institute of Technology"}]}], "datasetFiles": [{"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151129_H1975HGF_VehicleControl_TMT6.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151129_H1975HGF_VehicleControl_TMT6.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151129_H1975HGF_VehicleControl_TMT6.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151203_H1975_TargetEfficacy_TMT10.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151203_H1975_TargetEfficacy_TMT10.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151203_H1975_TargetEfficacy_TMT10.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151203_H1975_VehicleControl_TMT6.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151203_H1975_VehicleControl_TMT6.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151203_H1975_VehicleControl_TMT6.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151209_HCC827_VehicleControl_TMT6.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151209_HCC827_VehicleControl_TMT6.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151209_HCC827_VehicleControl_TMT6.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151216_H1975_TherapyResistance_CNTO4424_TMT6.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151216_H1975_TherapyResistance_CNTO4424_TMT6.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151216_H1975_TherapyResistance_CNTO4424_TMT6.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TargetEfficacy_TMT10.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TargetEfficacy_TMT10.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TargetEfficacy_TMT10.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TherapyResistance_AZD9291_TMT10.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TherapyResistance_AZD9291_TMT10.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TherapyResistance_AZD9291_TMT10.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TherapyResistance_CNTO4424_TMT10.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TherapyResistance_CNTO4424_TMT10.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151217_HCC827ER_TherapyResistance_CNTO4424_TMT10.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151218_HCC827_TargetEfficacy_TMT10.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151218_HCC827_TargetEfficacy_TMT10.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151218_HCC827_TargetEfficacy_TMT10.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151219_HCC827ER_VehicleControl_TMT6.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151219_HCC827ER_VehicleControl_TMT6.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151219_HCC827ER_VehicleControl_TMT6.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151220_HCC827_TherapyResistance_AZD9291_TMT6.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151220_HCC827_TherapyResistance_AZD9291_TMT6.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151220_HCC827_TherapyResistance_AZD9291_TMT6.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151221_H1975HGF_TargetEfficacy_TMT10.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151221_H1975HGF_TargetEfficacy_TMT10.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20151221_H1975HGF_TargetEfficacy_TMT10.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20160112_H1975HFG_TherapyResistance_CNTO4424_TMT6.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20160112_H1975HFG_TherapyResistance_CNTO4424_TMT6.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20160112_H1975HFG_TherapyResistance_CNTO4424_TMT6.raw"}, {"accession": "PRIDE:0000407", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20160112_H1975HGF_TherapyResistance_AZD9291_TMT10.dat-pride.xml.gz"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20160112_H1975HGF_TherapyResistance_AZD9291_TMT10.mgf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114/20160112_H1975HGF_TherapyResistance_AZD9291_TMT10.raw"}], "description": "Mass spectrometry-based quantitative proteomics profiling of in vivo signaling changes in 41 therapy resistant (osimertinib or EGFR/Met bispecific antibody treament) tumors from four xenograft NSCLC models.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/08/PXD006114"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD006114"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD006114"}, {"accession": "MS:1001922", "name": "Digital Object Identifier (DOI)", "value": "10.6019/PXD006114"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "NSCLC, EGFR, xenografts, drug resistance, tyrosine phosphorylation, mass spectrometry"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:01720", "name": "TMT6plex-126 reporter+balance reagent acylated residue"}, {"accession": "MOD:00696", "name": "phosphorylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "28830985"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Emdal KB, Dittmann A, Reddy RJ, Lescarbeau RS, Moores SL, Laquerre S, White FM. Characterization of in vivo resistance to osimertinib and JNJ-61186372, an EGFR/Met bi-specific antibody, reveals unique and consensus mechanisms of resistance. Mol Cancer Ther. 2017"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Phosphoproteomics of in vivo resistance to EGFR-targeted therapy in lung cancer cells"}